Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Y Terada

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|February 4, 2006
Sentinel node dissection in vulvar cancerAmy A Hakim, Keith Y Terada
Journal of Gynecologic Oncology|April 1, 2016
Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trialKeith Y Terada, Hyeong Jun Ahn, Bruce Kessel
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 21, 2013
Non-islet cell tumor hypoglycemia associated with recurrent carcinosarcoma of the ovaryGotaro Kojima, Keith Y Terada, Nobuyuki Miki, et al.
Journal of Gynecologic Oncology|April 23, 2016
Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancerTiffany Lai, Bruce Kessel, Hyeong Jun Ahn, et al.
Gynecologic Oncology|August 17, 2014
Abnormal CA-125 levels in menopausal women without ovarian cancerKeith Y Terada, Jennifer Elia, Robert Kim, et al.
Gynecologic Oncology|January 13, 2006
Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsyKeith Y Terada, David M Shimizu, Caroline S Jiang, et al.
Gynecologic Oncology|February 7, 2013
Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expressionKeith Y Terada, Michael Black, Laura H Terada, et al.
Gynecologic Oncology|May 24, 2012
Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expressionKassondra S Grzankowski, David M Shimizu, Chieko Kimata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor LesionsKoah Robin Vierkoetter, Laura A T Kagami, Hyeong Jun Ahn, et al.
Obstetrics and Gynecology|March 3, 2007
Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma riskGalina Lurie, Pamela Thompson, Katharine E McDuffie, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|February 4, 2006
Sentinel node dissection in vulvar cancerAmy A Hakim, Keith Y Terada
Journal of Gynecologic Oncology|April 1, 2016
Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trialKeith Y Terada, Hyeong Jun Ahn, Bruce Kessel
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 21, 2013
Non-islet cell tumor hypoglycemia associated with recurrent carcinosarcoma of the ovaryGotaro Kojima, Keith Y Terada, Nobuyuki Miki, et al.
Journal of Gynecologic Oncology|April 23, 2016
Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancerTiffany Lai, Bruce Kessel, Hyeong Jun Ahn, et al.
Gynecologic Oncology|August 17, 2014
Abnormal CA-125 levels in menopausal women without ovarian cancerKeith Y Terada, Jennifer Elia, Robert Kim, et al.
Gynecologic Oncology|January 13, 2006
Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsyKeith Y Terada, David M Shimizu, Caroline S Jiang, et al.
Gynecologic Oncology|February 7, 2013
Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expressionKeith Y Terada, Michael Black, Laura H Terada, et al.
Gynecologic Oncology|May 24, 2012
Clinical and pathologic features of young endometrial cancer patients with loss of mismatch repair expressionKassondra S Grzankowski, David M Shimizu, Chieko Kimata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2016
Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor LesionsKoah Robin Vierkoetter, Laura A T Kagami, Hyeong Jun Ahn, et al.
Obstetrics and Gynecology|March 3, 2007
Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma riskGalina Lurie, Pamela Thompson, Katharine E McDuffie, et al.
Pageof 2